Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-03 11:02 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 3,791,300 3.300% | -677,535 (-15.16%) | Filing History |
| 2023-10-05 09:00 am Purchase | 2023-10-05 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 7,922,170 7.400% | 7,922,170 (New Position) | Filing History |
| 2023-08-29 4:17 pm Purchase | 2023-08-28 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 5,366,452 5.000% | 143,013 (+2.74%) | Filing History |
| 2023-08-28 4:13 pm Purchase | 2023-08-21 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 5,223,439 4.900% | 1,599,537 (+44.14%) | Filing History |
| 2023-06-08 1:25 pm Sale | 2023-05-31 | 13G | Esperion Therapeutics, Inc. ESPR | BlackRock Inc. BLK | 4,645,359 4.900% | -863,828 (-15.68%) | Filing History |
| 2023-04-05 4:23 pm Purchase | 2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 4,533,756 5.000% | 2,095,618 (+85.95%) | Filing History |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 5.700% | -283,900 (-6.34%) | Filing History |
| 2023-02-14 4:14 pm Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 2,438,138 4.200% | -1,032,140 (-29.74%) | Filing History |
| 2023-02-14 11:14 am Sale | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 5,500,000 6.900% | -1,222,709 (-18.19%) | Filing History |
| 2023-02-10 1:46 pm Purchase | 2023-02-10 | 13G | Esperion Therapeutics, Inc. ESPR | WASATCH ADVISORS LP | 9,801,161 12.800% | 462,115 (+4.95%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Esperion Therapeutics, Inc. ESPR | The Vanguard Group | 4,260,464 5.780% | 499,025 (+13.27%) | Filing History |
| 2023-02-07 1:06 pm Purchase | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BlackRock Inc. BLK | 5,509,187 7.500% | 3,267,970 (+145.81%) | Filing History |
| 2023-01-20 4:13 pm Purchase | 2023-01-11 | 13G | Esperion Therapeutics, Inc. ESPR | Millennium Management LLC | 3,623,902 4.900% | 3,623,902 (New Position) | Filing History |
| 2023-01-04 2:30 pm Unchanged | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 4,468,835 6.100% | 0 (Unchanged) | Filing History |
| 2022-08-23 4:59 pm Purchase | 2022-08-22 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 3,470,278 5.200% | 3,470,278 (New Position) | Filing History |
| 2022-05-17 3:06 pm Sale | 2022-05-17 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 5,000,000 4.990% | -5,000,000 (-50.00%) | Filing History |
| 2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 6,722,709 9.900% | 448,324 (+7.15%) | Filing History |
| 2022-02-11 4:39 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 7.100% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:09 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 10,000,000 8.060% | 0 (Unchanged) | Filing History |
| 2022-02-11 2:54 pm Purchase | 2022-02-11 | 13G | Esperion Therapeutics, Inc. ESPR | WASATCH ADVISORS LP | 9,339,046 14.400% | 5,341,036 (+133.59%) | Filing History |